Randomized, controlled crossover trial of dronabinol, 2.5 mg, for agitation in 2 patients with dementia.

Category Primary study
JournalJournal of clinical psychopharmacology
Year 2011
Loading references information
This article has no abstract
Epistemonikos ID: 61cd07117ffd260060ac2bc706f3bbcf0717e807
First added on: May 08, 2015